The Federal Trade Commission is suing the three largest prescription drug benefit managers (PBMs) for allegedly driving up ...
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...
The complaint targets the group purchasing organizations affiliated with the "big three" pharmacy benefit managers: CVS ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
20hon MSN
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...
The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...
FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback